ADC-induced Neurotoxicity Treated With Duloxetine
NCT06551051
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
37
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumour
Interventions
DRUG:
duloxetine
Sponsor
Fudan University